Abbott India (AbbotIndia) - every time in the past stock correction was followed by a minimum 100% rally. 30% up move already and the stock has now crossed its all-time high. Will it give the same move again?
Must have portfolio stock. It is FMCG of Pharma.
More from Steve Nison
Laurus Labs - Double top buy will be activated above closing of 690. Target still active: 895 (1%*3 box size and reversal)
✅✅ https://t.co/MtJOLfpzYj
✅✅ https://t.co/MtJOLfpzYj
Laurus Labs - I am waiting till 3:15 PM to get confirmation of closing above 700 to add more of it in my portfolio. \u2705\u2705 pic.twitter.com/UxZCuxhuIX
— Steve Nison (@nison_steve) August 9, 2021
H&S tops with ascending/descending necklines https://t.co/cmRRHp5rlh
Sir Edwards & Magee discussed sloping necklines in H&S in their classical work. I am considering this breakdown by Affle as an H&S top breakdown with a target open of 770.
— The_Chartist \U0001f4c8 (@charts_zone) May 25, 2022
The target also coincides with support at the exact same level. pic.twitter.com/n84kSgkg4q
You May Also Like
Moderna CEO Stephane Bancel was previously CEO of bioMerieux in France from 07-10.
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI
"I lied about my basic beliefs in order to keep a prestigious job. Now that it will be zero-cost to me, I have a few things to say."
We know that elite institutions like the one Flier was in (partial) charge of rely on irrelevant status markers like private school education, whiteness, legacy, and ability to charm an old white guy at an interview.
Harvard's discriminatory policies are becoming increasingly well known, across the political spectrum (see, e.g., the recent lawsuit on discrimination against East Asian applications.)
It's refreshing to hear a senior administrator admits to personally opposing policies that attempt to remedy these basic flaws. These are flaws that harm his institution's ability to do cutting-edge research and to serve the public.
Harvard is being eclipsed by institutions that have different ideas about how to run a 21st Century institution. Stanford, for one; the UC system; the "public Ivys".
As a dean of a major academic institution, I could not have said this. But I will now. Requiring such statements in applications for appointments and promotions is an affront to academic freedom, and diminishes the true value of diversity, equity of inclusion by trivializing it. https://t.co/NfcI5VLODi
— Jeffrey Flier (@jflier) November 10, 2018
We know that elite institutions like the one Flier was in (partial) charge of rely on irrelevant status markers like private school education, whiteness, legacy, and ability to charm an old white guy at an interview.
Harvard's discriminatory policies are becoming increasingly well known, across the political spectrum (see, e.g., the recent lawsuit on discrimination against East Asian applications.)
It's refreshing to hear a senior administrator admits to personally opposing policies that attempt to remedy these basic flaws. These are flaws that harm his institution's ability to do cutting-edge research and to serve the public.
Harvard is being eclipsed by institutions that have different ideas about how to run a 21st Century institution. Stanford, for one; the UC system; the "public Ivys".
